Indian Pharma Shouldn’t Be Driven by Tariffs, Says Cipla CEO
Cipla‘s CEO stated on Friday that tariffs should not dictate the operations of Indian pharmaceutical companies as the industry anticipates U.S. President Donald Trump’s proposed taxes on drug imports. India,…